Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Lavelle Erin Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Lavelle Erin (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.79, valued at $19.8k
11/02/2022 4 Lavelle Erin (COO & CFO) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 170,000 options to buy @ $3.27, valued at $555.9k
05/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2022 4 Lavelle Erin (COO & CFO) has filed a Form 4 on Eliem Therapeutics, Inc.
Txns: Granted 170,000 options to buy @ $8.21, valued at $1.4M
10/24/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2019 4 Lavelle Erin (COO) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 5,842 shares @ $0
Sold 1,434 shares @ $13.6676, valued at $19.6k
02/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/18/2018 4 Lavelle Erin (Chief Commercial Officer) has filed a Form 4 on ALDER BIOPHARMACEUTICALS INC
Txns: Granted 300,000 options to buy @ $14.55, valued at $4.4M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy